SIR Institute for Pharmacy Practice and Policy
- Research works
- 52 ▲ 40% vs 2013–17
- Citations
- 1.6k 30.5 per fractional work
- Top-10% rate
- 11.5% record average 16.5%
- Open access
- 70% world 28%
Not ranked overall: SIR Institute for Pharmacy Practice and Policy is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 5.1×. Every wedge is a field page.
- Health Professions 5.1×
- Pharmacology, Toxicology and Pharmaceutics 4.6×
- Arts and Humanities 3.2×
- Medicine 2.7×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Immunology and Microbiology 1.4×
- Nursing 1.3×
- Psychology 1.0×
- Decision Sciences 0.6×
- Social Sciences 0.6×
- Business, Management and Accounting 0.3×
- Earth and Planetary Sciences 0.0×
Which keywords describe research at SIR Institute for Pharmacy Practice and Policy?
By fractional works in all years, weighted toward what it does more of than the world: Elderly, Inappropriate Medication Use, Polypharmacy, Medication Adherence, Chronic Disease Management, Health Outcomes, Cardiovascular Disease Prevention and Patient Compliance.
- Patient Safety Culture
- Comorbidity
- Type 2 Diabetes
- Off-Label Drug Use
- Ethical Issues
- Clinical Decision Support Systems
- Genetic Variation
- Guidelines
- Heart Failure
- Primary Care
- Clinical Trials
- Behavior Change
- Signal Detection
- Treatment
- Inflammation
- Epidemiology
- Patient Compliance
- Cardiovascular Disease Prevention
- Medication Adherence
- Inappropriate Medication Use
- Elderly
- Polypharmacy
- Chronic Disease Management
- Health Outcomes
- Treatment Adherence
- Adverse Drug Reactions
- Medication Errors
- Pharmacovigilance
- Quality of Life
- Cardiovascular Disease
- Metabolic Syndrome
- Clinical Guidelines
- Glycemic Control
- Adverse Events
- Healthcare Quality
- Electronic Health Records
- Insulin Therapy
- Pediatric Pharmacokinetics
- Cardiovascular Outcomes
- Medical Errors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Elderly9▲ 68×2 topics
- Inappropriate Medication Use9▲ 418×1 topic
- Polypharmacy9▲ 418×1 topic
- Medication Adherence6▲ 211×2 topics
- Chronic Disease Management6▲ 79×4 topics
- Cardiovascular Disease Prevention5▲ 130×2 topics
- Health Outcomes5▲ 45×2 topics
- Patient Compliance5▲ 482×1 topic
- Treatment Adherence5▲ 482×1 topic
- Epidemiology4▲ 1.95×15 topics
- Adverse Drug Reactions4▲ 103×3 topics
- Inflammation2▲ 1.90×9 topics
- Medication Errors2▲ 90×2 topics
- Treatment2▲ 3.4×7 topics
- Pharmacovigilance2▲ 329×1 topic
- Signal Detection2▲ 329×1 topic
- Quality of Life2▲ 3.0×8 topics
- Behavior Change2▲ 34×3 topics
- Cardiovascular Disease2▲ 3.2×8 topics
- Clinical Trials2▲ 5.9×7 topics
- Metabolic Syndrome2▲ 4.3×5 topics
- Primary Care2▲ 8.7×7 topics
- Clinical Guidelines2▲ 11×4 topics
- Heart Failure2▲ 7.5×3 topics
- Glycemic Control2▲ 23×3 topics
- Guidelines2▲ 6.4×3 topics
- Adverse Events1▲ 42×2 topics
- Genetic Variation1▲ 7.9×3 topics
- Healthcare Quality1▲ 20×3 topics
- Clinical Decision Support Systems1▲ 86×1 topic
- Electronic Health Records1▲ 37×1 topic
- Ethical Issues1▲ 24×2 topics
- Insulin Therapy1▲ 20×2 topics
- Off-Label Drug Use1▲ 60×1 topic
- Pediatric Pharmacokinetics1▲ 60×1 topic
- Type 2 Diabetes1▲ 12×2 topics
- Cardiovascular Outcomes1▲ 49×1 topic
- Comorbidity1▲ 22×2 topics
- Medical Errors1▲ 59×1 topic
- Patient Safety Culture1▲ 94×1 topic
Which research topics does SIR Institute for Pharmacy Practice and Policy publish most on?
By volume in 2022–2025: Pharmaceutical Practices and Patient Outcomes, Medication Adherence and Compliance, Nutrition, Genetics, and Disease and Patient-Provider Communication in Healthcare.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 2 works
- 2 Medication Adherence and Compliance Family Practice 1 works
- 3 Nutrition, Genetics, and Disease Genetics 1 works
- 4 Patient-Provider Communication in Healthcare General Health Professions 0 works
- 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 6 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 0 works
- 7 Pain Management and Opioid Use Anesthesiology and Pain Medicine 0 works
- 8 Historical and Linguistic Studies Sociology and Political Science 0 works
- 9 Linguistics and Cultural Studies Language and Linguistics 0 works
- 10 Medieval and Classical Philosophy Philosophy 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has SIR Institute for Pharmacy Practice and Policy's research output changed?
Output in 2018–2022 was 40% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Leiden
- Leiden University
- Leiden University Medical Center
- Naturalis Biodiversity Center
- Space Research Organisation Netherlands
- University of Applied Sciences Leiden
- Centre for Human Drug Research
- Royal Netherlands Institute of Southeast Asian and Caribbean Studies
- African Studies Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.